NeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb

Additional funding will be used to explore novel biology around the MMR pathway and accelerate progression of the lead program into candidate selectionLONDON, May 22, 2024 /PRNewswire/ -- NeoPhore

Related Keywords

London ,City Of ,United Kingdom ,Matthew Baker ,Bristol Myers Squibb ,Robert James ,Phoremost Ltd ,Pioneer Fund ,Linkedin ,Facebook ,Neophore Ltd ,Bristol Myers Squibb Company ,Prnewswire Neophore ,Twitter ,University Of Turin ,Youtube ,Instagram ,Phore Limited ,Chief Executive Officer ,Myers Squibb ,Ihr Portfolio ,